GSK3B and Cognitive impairment: LiCl improved the SEV‐induced cognitive impairment by inhibiting apoptosis and oxidative stress through suppression of the GSK‐3β/β‐catenin signaling pathway, and LiCl could become a therapeutic agent in treating SEV anesthesia‐induced neurodegeneration.